Filter Binding Assay
Filter Binding Assay - Related Videos
04:05
Competition Binding Assay to Study Competing GTPase-Binding Protein Partners
0 Views •
2025
This video demonstrates a competition assay to study GTPase-binding protein partners. Utilizing nucleotide-bound GTPase protein immobilized on magnetic beads, the competitive binding between two interacting protein partners for the same binding site on the GTPase can be studied to assess the binding affinities of the protein partners.
07:53
Actin Co-Sedimentation Assay; for the Analysis of Protein Binding to F-Actin
0 Views •
Cited by 18 •
2008
Proteins bind to filamentous actin (F-actin) through distinct actin binding modules. In this video we demonstrate the procedure of actin co-sedimentation, which is an in vitro assay routinely used to analyze proteins or specific domains that bind F-actin.
09:32
Evaluating the Effect of Coated Filters and Pre-Filters on the Infectivity and Concentration of Aerosolized Phi6 Virus
0 Views •
2026
Here, we present a study to evaluate the anti-viral efficacy of copper- and silver-based surface coatings on air filters. Using a bioaerosol chamber and Phi6 bacteriophage, this method quantifies viral inactivation and mechanical filtration efficiency for self-sanitizing indoor air technologies.
06:30
SELEX-Based In Vitro Binding Assay to Identify RNA-Protein Interactions
0 Views •
2025
In this video, we describe the systematic evolution of ligands by the exponential enrichment (SELEX) method to identify specific RNA-binding sequences for a target protein of interest. The protein is incubated with a large pool of randomized RNA sequences, and the protein-binding RNA sequences are isolated, PCR-amplified, and sequenced to identify their protein-binding sites.
07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
0 Views •
Cited by 21 •
2014
Biochemical assays with recombinant human MHC II molecules can provide rapid, quantitative insights into immunogenic epitope identification, deletion, or design. Here, a peptide-MHC II binding assay scaled to 384-well plates is described. This cost effective format should prove useful in the fields of protein deimmunization and vaccine design and development.
FAQs
The assay separates binding signal from free ligand through filtration and washing. Receptor-containing membranes are retained on a glass-fiber filter, while washing removes molecules that have not remained associated with the captured material. The radioactivity left on the filter therefore serves as the measured signal for ligand-target binding, allowing binding strength to be compared across conditions.
Researchers vary the concentration of labeled ligand and examine how the retained radioactivity changes. These measurements provide information used to estimate affinity, meaning binding strength, and binding-site density, meaning the amount of available target. Considering both properties helps distinguish a target that binds tightly from one that offers a larger number of binding sites.
A competing compound tests whether another molecule can interfere with labeled ligand binding. If it reduces the amount of labeled ligand retained on the filter, the change provides evidence relevant to receptor selectivity and pharmacological activity. Comparing different competitors can therefore help characterize how compounds interact with targets involved in neurotransmitter systems.
The core sequence begins by incubating receptor-containing membranes with a labeled ligand. The mixture is then passed through a glass-fiber filter so the receptor-containing material is captured, followed by washing to remove unbound molecules. Measuring the radioactivity retained after washing converts the ligand-target interaction into an experimental binding signal.
Receptor-containing membranes provide the target material needed to measure ligand interactions associated with neurotransmitter systems. This allows researchers to examine how strongly labeled ligands bind to receptor targets and how that binding changes when ligand concentrations or competing compounds are varied. The resulting measurements support characterization of receptor-related signaling mechanisms in neuroscience.
Affinity measurements show how strongly compounds interact with receptor targets, while competition experiments provide information about selectivity and pharmacological activity. Together, these results help researchers evaluate compounds that may alter receptor-mediated neuronal signaling. The assay therefore contributes biochemical evidence for studying neurotransmitter systems and identifying molecules with potentially useful receptor-modulating properties.